Molecular and Cellular Angiogenesis

[1]  Till Acker,et al.  Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions , 2001, Nature Medicine.

[2]  R K Jain,et al.  Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[3]  P. Carmeliet.  Developmental biology: One cell, two fates , 2000, Nature.

[4]  Jun Yamashita,et al.  Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors , 2000, Nature.

[5]  C. Steidl,et al.  Analysis of HeyL expression in wild-type and Notch pathway mutant mouse embryos , 2000, Mechanisms of Development.

[6]  M. Simons,et al.  Thrombospondin Type 1 Repeats Interact with Matrix Metalloproteinase 2 , 2000, The Journal of Biological Chemistry.

[7]  C. Mailhos,et al.  Vascular developmental biology: getting nervous. , 2000, Current opinion in genetics & development.

[8]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[9]  G. Semenza,et al.  HIF-1 and human disease: one highly involved factor. , 2000, Genes & development.

[10]  P. Carmeliet.  Fibroblast growth factor-1 stimulates branching and survival of myocardial arteries: a goal for therapeutic angiogenesis? , 2000, Circulation research.

[11]  P. Doevendans,et al.  Transgenic Myocardial Overexpression of Fibroblast Growth Factor-1 Increases , 2022 .

[12]  J. M. Arbeit,et al.  Hypoxia-inducible Factor-1α Is a Positive Factor in Solid Tumor Growth , 2000 .

[13]  J W Baish,et al.  Fractals and cancer. , 2000, Cancer research.

[14]  M. Burdick,et al.  CXC chemokines in angiogenesis , 2000, Journal of leukocyte biology.

[15]  A. Mazar,et al.  A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  J. Isner,et al.  Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. , 2000, Circulation research.

[17]  Y. Hiraki,et al.  Chondromodulin-I as a novel cartilage-specific growth-modulating factor , 2000, Pediatric Nephrology.

[18]  H. Paradis,et al.  Tubedown‐1, A novel acetyltransferase associated with blood vessel development , 2000, Developmental dynamics : an official publication of the American Association of Anatomists.

[19]  J. Sundberg,et al.  Notch signaling is essential for vascular morphogenesis in mice. , 2000, Genes & development.

[20]  M. Kennedy,et al.  A transitional stage in the commitment of mesoderm to hematopoiesis requiring the transcription factor SCL/tal-1. , 2000, Development.

[21]  W. Richards,et al.  Dll4, a novel Notch ligand expressed in arterial endothelium. , 2000, Genes & development.

[22]  G. Koh,et al.  Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion. , 2000, Circulation research.

[23]  J. Pouysségur,et al.  Signaling Angiogenesis via p42/p44 MAP Kinase Cascade , 2000, Annals of the New York Academy of Sciences.

[24]  G. Davis,et al.  RGD-Dependent Vacuolation and Lumen Formation Observed during Endothelial Cell Morphogenesis in Three-Dimensional Fibrin Matrices Involves the αvβ3 and α5β1 Integrins , 2000 .

[25]  L. Mayo,et al.  Tumor Necrosis Factor Employs a Protein-tyrosine Phosphatase to Inhibit Activation of KDR and Vascular Endothelial Cell Growth Factor-induced Endothelial Cell Proliferation* , 2000, The Journal of Biological Chemistry.

[26]  W. Thomas,et al.  Cellular mechanisms of CNS pericytes , 2000, Brain Research Bulletin.

[27]  R K Jain,et al.  Openings between defective endothelial cells explain tumor vessel leakiness. , 2000, The American journal of pathology.

[28]  N. Glazer,et al.  Angiopoietin-1 protects the adult vasculature against plasma leakage , 2000, Nature Medicine.

[29]  P. Carmeliet.  Mechanisms of angiogenesis and arteriogenesis , 2000, Nature Medicine.

[30]  R. Kalb,et al.  Angiopoietin-1 Inhibits Endothelial Cell Apoptosis via the Akt/Survivin Pathway* , 2000, The Journal of Biological Chemistry.

[31]  M. Fishman,et al.  gridlock, an HLH gene required for assembly of the aorta in zebrafish. , 2000, Science.

[32]  K. Brew,et al.  Tissue inhibitors of metalloproteinases: evolution, structure and function. , 2000, Biochimica et biophysica acta.

[33]  B. Fingleton,et al.  Matrix metalloproteinases: biologic activity and clinical implications. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  T. Štefanec.  Endothelial apoptosis: could it have a role in the pathogenesis and treatment of disease? , 2000, Chest.

[35]  A. Pozzi,et al.  Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[36]  S A Tschanz,et al.  Intussusceptive angiogenesis: its role in embryonic vascular network formation. , 2000, Circulation research.

[37]  G. Kay,et al.  Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. , 2000, Circulation research.

[38]  H. Dvorak,et al.  VPF/VEGF and the angiogenic response. , 2000, Seminars in perinatology.

[39]  M. Knaapen,et al.  The role of apoptosis in vascular disease , 2000, The Journal of pathology.

[40]  D. McDonald,et al.  Determinants of Endothelial Cell Phenotype in Venules , 2000, Microcirculation.

[41]  I. Buschmann,et al.  The pathophysiology of the collateral circulation (arteriogenesis) , 2000, The Journal of pathology.

[42]  D. Srivastava,et al.  The basic helix-loop-helix transcription factor, dHAND, is required for vascular development. , 2000, The Journal of clinical investigation.

[43]  R Folberg,et al.  Vasculogenic mimicry and tumor angiogenesis. , 2000, The American journal of pathology.

[44]  T. Veikkola,et al.  Regulation of angiogenesis via vascular endothelial growth factor receptors. , 2000, Cancer research.

[45]  I. Stamenkovic,et al.  Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. , 2000, Genes & development.

[46]  A. Brändli,et al.  The receptor tyrosine kinase EphB4 and ephrin-B ligands restrict angiogenic growth of embryonic veins in Xenopus laevis. , 2000, Development.

[47]  P. Schwartzberg,et al.  Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. , 1999, Molecular cell.

[48]  C. Shovlin.  Supermodels and disease: insights from the HHT mice. , 1999, The Journal of clinical investigation.

[49]  M. Rabinovitch.  Pulmonary hypertension: pathophysiology as a basis for clinical decision making. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[50]  P. Carmeliet.  Developmental biology: Controlling the cellular brakes , 1999, Nature.

[51]  W. Gerald,et al.  Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts , 1999, Nature.

[52]  C. Compton,et al.  Tumor–host interactions in the gallbladder suppress distal angiogenesis and tumor growth: Involvement of transforming growth factor β1 , 1999, Nature Medicine.

[53]  M. Bardou,et al.  Hypoxic pulmonary vasoconstriction. , 1999, General pharmacology.

[54]  A. Luttun,et al.  Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure , 1999, Nature Medicine.

[55]  D. Rimm,et al.  PECAM-1 (CD31) functions as a reservoir for and a modulator of tyrosine-phosphorylated beta-catenin. , 1999, Journal of cell science.

[56]  N. Ferrara.  Role of vascular endothelial growth factor in the regulation of angiogenesis. , 1999, Kidney international.

[57]  P. Meltzer,et al.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. , 1999, The American journal of pathology.

[58]  M. Corada,et al.  Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[59]  E. Dejana,et al.  Molecular structure and functional role of vascular tight junctions. , 1999, Trends in cardiovascular medicine.

[60]  P. Carmeliet,et al.  Targeted Deficiency or Cytosolic Truncation of the VE-cadherin Gene in Mice Impairs VEGF-Mediated Endothelial Survival and Angiogenesis , 1999, Cell.

[61]  J. Isner,et al.  VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells , 1999, The EMBO journal.

[62]  S. Tsukita,et al.  Occludin and claudins in tight-junction strands: leading or supporting players? , 1999, Trends in cell biology.

[63]  J. Peng,et al.  Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. , 1999, Development.

[64]  G. Yancopoulos,et al.  Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. , 1999, Science.

[65]  B. Brooke,et al.  Defective angiogenesis in mice lacking endoglin. , 1999, Science.

[66]  C. Wykoff,et al.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.

[67]  G. Weinmaster,et al.  Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. , 1999, Human molecular genetics.

[68]  D. Cheresh,et al.  The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. , 1999, The Journal of clinical investigation.

[69]  Willem Flameng,et al.  Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 , 1999, Nature Medicine.

[70]  G. Yancopoulos,et al.  Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. , 1999, Genes & development.

[71]  A. Lane,et al.  Surface densities of ephrin‐B1 determine EphB1‐coupled activation of cell attachment through αvβ3 and α5β1 integrins , 1999 .

[72]  J. Glanz.  Hawking Blesses the Accelerating Universe , 1999, Science.

[73]  R. Lang,et al.  VEGF deprivation-induced apoptosis is a component of programmed capillary regression. , 1999, Development.

[74]  Haruchika Masuda,et al.  Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization , 1999, Nature Medicine.

[75]  J. D. Brown,et al.  MEKK-1, a Component of the Stress (Stress-activated Protein Kinase/c-Jun N-terminal Kinase) Pathway, Can Selectively Activate Smad2-mediated Transcriptional Activation in Endothelial Cells* , 1999, The Journal of Biological Chemistry.

[76]  H. Stuhlmann,et al.  Vezf1: A Zn finger transcription factor restricted to endothelial cells and their precursors. , 1999, Developmental biology.

[77]  F. Diella,et al.  Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. , 1999, Genes & development.

[78]  G. Lyons,et al.  Requirement of the MADS-box transcription factor MEF2C for vascular development. , 1998, Development.

[79]  K. Alitalo,et al.  Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. , 1998, Science.

[80]  Thomas N. Sato,et al.  Increased vascularization in mice overexpressing angiopoietin-1. , 1998, Science.

[81]  V. Castronovo,et al.  Expression and modulation of homeobox genes from cluster B in endothelial cells. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[82]  C. Betsholtz,et al.  Endothelial-perivascular cell signaling in vascular development: lessons from knockout mice. , 1998, Current opinion in lipidology.

[83]  G. Semenza.  Hypoxia-inducible factor 1: master regulator of O2 homeostasis. , 1998, Current opinion in genetics & development.

[84]  P. Carmeliet,et al.  Development and disease in proteinase-deficient mice: role of the plasminogen, matrix metalloproteinase and coagulation system. , 1998, Thrombosis research.

[85]  J. Ruiz,et al.  Ephrin-A1 is expressed at sites of vascular development in the mouse , 1998, Mechanisms of Development.

[86]  R K Jain,et al.  Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[87]  W. Risau,et al.  Development and differentiation of endothelium. , 1998, Kidney international. Supplement.

[88]  R. A. Gomez.  Role of angiotensin in renal vascular development. , 1998, Kidney international. Supplement.

[89]  M. Skobe,et al.  Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization , 1998, Nature Medicine.

[90]  P. Carmeliet,et al.  Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis , 1998, Nature.

[91]  N. Perrimon,et al.  Tout-velu is a Drosophila homologue of the putative tumour suppressor EXT-1 and is needed for Hh diffusion , 1998, Nature.

[92]  David J. Anderson,et al.  Molecular Distinction and Angiogenic Interaction between Embryonic Arteries and Veins Revealed by ephrin-B2 and Its Receptor Eph-B4 , 1998, Cell.

[93]  Dean Y. Li,et al.  Elastin is an essential determinant of arterial morphogenesis , 1998, Nature.

[94]  Gabriele Bergers,et al.  MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes , 1998, Cell.

[95]  E. Keshet,et al.  A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. , 1998, Development.

[96]  R. Jain,et al.  Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[97]  P. Huang,et al.  Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. , 1998, The Journal of clinical investigation.

[98]  D. Cheresh,et al.  Disruption of Angiogenesis by PEX, a Noncatalytic Metalloproteinase Fragment with Integrin Binding Activity , 1998, Cell.

[99]  W. Denetclaw,et al.  Common epicardial origin of coronary vascular smooth muscle, perivascular fibroblasts, and intermyocardial fibroblasts in the avian heart. , 1998, Developmental biology.

[100]  D. Cheresh,et al.  Induction of the Angiogenic Phenotype by Hox D3 , 1997, The Journal of cell biology.

[101]  H. Dietz,et al.  Targetting of the gene encoding fibrillin–1 recapitulates the vascular aspect of Marfan syndrome , 1997, Nature Genetics.

[102]  K. Alitalo,et al.  Bmx tyrosine kinase is specifically expressed in the endocardium and the endothelium of large arteries. , 1997, Circulation.

[103]  R K Jain,et al.  Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. , 1997, The American journal of pathology.

[104]  A. Elefanty,et al.  Hematopoietic-specific genes are not induced during in vitro differentiation of scl-null embryonic stem cells. , 1997, Blood.

[105]  Thomas N. Sato,et al.  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.

[106]  Janet Rossant,et al.  A Requirement for Flk1 in Primitive and Definitive Hematopoiesis and Vasculogenesis , 1997, Cell.

[107]  David Baunoch,et al.  Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT , 1997, Nature.

[108]  M. Pepper,et al.  Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. , 1997, Cytokine & growth factor reviews.

[109]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[110]  Pamela F. Jones,et al.  Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.

[111]  R. Montesano,et al.  An Antisense Oligonucleotide to the Notch Ligand Jagged Enhances Fibroblast Growth Factor-induced Angiogenesis in Vitro* , 1996, The Journal of Biological Chemistry.

[112]  M. Nehls,et al.  Shear stress inhibits apoptosis of human endothelial cells , 1996, FEBS letters.

[113]  W. Schaper,et al.  Molecular mechanisms of coronary collateral vessel growth. , 1996, Circulation research.

[114]  S. Miller,et al.  Wall remodeling during luminal expansion of mesenteric arterial collaterals in the rat. , 1996, Circulation research.

[115]  K. Hirschi,et al.  Pericytes in the microvasculature. , 1996, Cardiovascular research.

[116]  Kenneth J. Hillan,et al.  Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene , 1996, Nature.

[117]  Lieve Moons,et al.  Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele , 1996, Nature.

[118]  R. Jain,et al.  Intussusceptive microvascular growth in a human colon adenocarcinoma xenograft: a novel mechanism of tumor angiogenesis. , 1996, Microvascular research.

[119]  D. Cheresh,et al.  Review: The Integrin αvβ3: Angiogenesis and Apoptosis , 1995 .

[120]  J. Stone,et al.  Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity , 1995, Nature Medicine.

[121]  S. Kourembanas,et al.  Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer. , 1995, Circulation research.

[122]  Janet Rossant,et al.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.

[123]  W. Risau.  Differentiation of endothelium , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[124]  D. Cheresh,et al.  Integrin α v β 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels , 1994, Cell.

[125]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[126]  E. Keshet,et al.  Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. , 1994, Cardiovascular research.

[127]  W. Risau,et al.  Induction of vasculogenesis in quail blastodisc-derived embryoid bodies. , 1994, Developmental biology.

[128]  D. Cheresh,et al.  Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.

[129]  J. Rossant,et al.  flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. , 1993, Development.

[130]  D. Noden.  Embryonic origins and assembly of blood vessels. , 1989, The American review of respiratory disease.

[131]  B. Vandenbunder,et al.  Complementary patterns of expression of c-ets 1, c-myb and c-myc in the blood-forming system of the chick embryo. , 1989, Development.

[132]  S. Rafii,et al.  Circulating endothelial precursors: mystery, reality, and promise. , 2000, The Journal of clinical investigation.

[133]  P. Carmeliet,et al.  PR39, a peptide regulator of angiogenesis , 2000, Nature Medicine.

[134]  M. Makuuchi,et al.  Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. , 2000, Blood.

[135]  G. Semenza.  Expression of hypoxia-inducible factor 1: mechanisms and consequences. , 2000, Biochemical pharmacology.

[136]  D. Wilkinson,et al.  Eph receptors and ephrins: regulators of guidance and assembly. , 2000, International review of cytology.

[137]  N. Ferrara,et al.  Vascular endothelial growth factor and the regulation of angiogenesis. , 2000, Recent progress in hormone research.

[138]  R. Hebbel,et al.  Origins of circulating endothelial cells and endothelial outgrowth from blood. , 2000, The Journal of clinical investigation.

[139]  Dian Feng,et al.  Heterogeneity of the Angiogenic Response Induced in Different Normal Adult Tissues by Vascular Permeability Factor/Vascular Endothelial Growth Factor , 2000, Laboratory Investigation.

[140]  C. Betsholtz,et al.  Role of platelet-derived growth factors in angiogenesis and alveogenesis. , 1999, Current topics in pathology. Ergebnisse der Pathologie.

[141]  V. Vincenti,et al.  Structure, expression and receptor-binding properties of placenta growth factor (PlGF). , 1999, Current topics in microbiology and immunology.

[142]  M. Gimbrone,et al.  Blood flow and vascular gene expression: fluid shear stress as a modulator of endothelial phenotype. , 1999, Molecular medicine today.

[143]  K. Alitalo,et al.  Structure, expression and receptor-binding properties of novel vascular endothelial growth factors. , 1999, Current topics in microbiology and immunology.

[144]  L. Rubin,et al.  The cell biology of the blood-brain barrier. , 1999, Annual review of neuroscience.

[145]  K. Johnson,et al.  A role for cadherins in cellular signaling and differentiation , 1998, Journal of cellular biochemistry. Supplement.

[146]  R. Beddington,et al.  Hex: a homeobox gene revealing peri-implantation asymmetry in the mouse embryo and an early transient marker of endothelial cell precursors. , 1998, Development.

[147]  L. Leatherbury,et al.  Role of cardiac neural crest cells in cardiovascular development. , 1998, Annual review of physiology.

[148]  K. Choi,et al.  Hemangioblast development and regulation. , 1998, Biochemistry and cell biology = Biochimie et biologie cellulaire.